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Schizophrenia: A gene at 6p? 
Elisabeth Dawson and Robin Murray
Schizophrenia often exhibits familial clustering; this is
suggestive of heritable factors, but the whereabouts of
responsible gene(s) has remained elusive. Recent
research suggests that a region of chromosome 6p may
hold some of the answers.
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Approximately one in every 100 individuals will develop
schizophrenia during the course of his or her life. The
symptoms typically emerge in the late teens and twenties:
schizophrenia disrupts an individual’s thought processes,
perceptions, emotions and behaviour. Sufferers lose touch
with reality, developing false beliefs (delusions) and expe-
riencing abnormal perceptions — in particular, auditory
hallucinations or ‘voices’. They may also show poverty in
the amount and content of speech, poor working memory,
and inappropriate mood and behaviour. The frequent hos-
pitalizations, profound psychosocial impairment, and high
incidence of suicide ensure that schizophrenia is a major
public health concern. 
Little is known regarding the aetiology and pathophysiology
of the illness, and diagnosis is therefore wholly based on
the clinical presentation. The boundaries of schizophrenia
are unclear, however, and several ‘schizophrenia-like’ syn-
dromes exist; such symptoms can be caused by other
mental illness, physical illness, prescription medications,
illicit drugs or brain injury [1]. Currently, there is no way
to prevent or cure schizophrenia, although antipsychotic
medications can control some symptoms. Schizophrenia is
known to cluster in families, suggesting a genetic
contribution to its aetiology. The nature of this contribu-
tion is naturally of great interest, but attempts to find
responsible gene(s) have so far met with little success.
New results suggest such a gene may reside in a region of
chromosome 6p.
Genetic epidemiology 
Schizophrenia is more common among the relatives of
schizophrenics than in the population at large. One of the
earliest propronents of a role for genetic factors was
Charles Darwin (1809–1882): “With man we see... that
genius, which implies a wonderfully complex combination
of high faculties, tends to be inherited; and... that insanity
and deteriorated mental powers likewise run in families”
[2]. Following the delineation of schizophrenia at the turn
of this century by Kraepelin and Bleuler, family, twin and
adoption studies have added weight to Darwin’s observa-
tion (reviewed in [3,4]). Family studies show that, in
aggregate, first-degree relatives of an individual with
schizophrenia have approximately ten-times the general
population risk of developing the disorder. Modern (after
1967) twin studies show that an identical (monozygotic)
twin of someone with schizophrenia exhibits the disorder
~50% of the time, compared with 10 % for a fraternal
(dizygotic) twin. Similarly, adoption studies have, without
exception, found increased rates of schizophrenia in the
biological relatives of schizophrenic adoptees but not in
their adoptive relatives.
Although a large literature discusses the weaknesses of
such behavioural genetic studies of schizophrenia, in
aggregate they suggest that shared genes rather than
shared environments underlie the increased risk of illness
in the relatives of affected individuals. The genetic contri-
bution to schizophrenia — its heritability — has been esti-
mated to be ~70 %; this leaves room for environmental
mechanisms also. Gene–environment interactions are
therefore likely; for example, a Danish study found that
the risk of schizophrenia to the children of unaffected
monozygotic co-twins equalled that of the affected twins’
offspring [5]. This lack of penetrance of the genetic
factor(s) in the unaffected twin could possibly be due to a
lack of interaction with a specific environmental agent.
Hence, what is inherited is not the certainty of disease
accompanying a particular genotype but rather a predispo-
sition or liability to develop the disorder. The question
then arises as to what the genetic component is.
Mode of inheritance
Known inherited diseases display a variety of transmissible
factors (one gene, few genes, polygenes, genes on sex
chromosomes), transmission patterns (dominant, reces-
sive), interactions with the environment, and effects of
population dynamics on the mutation. Most of the poten-
tial modes of inheritance have been suggested, at some
time or other, to apply to schizophrenia [1].
Diseases caused by mutations in single genes are usually
relatively rare and show very specific, Mendelian patterns
of inheritance. The fact that schizophrenia is relatively
common and complex in its pattern of inheritance is not
conducive to a single-gene hypothesis, although modifica-
tions to Mendelian ratios, such as incomplete penetrance
and/or variable expressivity, can occur. Other genetic phe-
nomena — genomic imprinting, anticipation, mitochondrial
inheritance or partial sex-linkage — could also be relevant
to schizophrenia. Phenocopies — affected individuals
without the disease genotype, in whom the disease is
caused by environmental factors — may also obscure a
Mendelian inheritance pattern. For example, patients
with temporal lobe epilepsy may manifest schizophrenic
symptoms. In addition, obstetric difficulties before or at
the time of the birth have been established as a risk factor,
and the abuse of drugs such as LSD (lysergic acid diethy-
lamide) or amphetamines may precipitate the disorder.
An alternative to a single-gene hypothesis is that an
unspecified, large number of independently segregating
loci (‘polygenes’) contribute additively to the phenotype.
It has been argued [6], on the basis of animal breeding
experiments, as well as human studies, that multiple
genes are responsible for the genetic influences on behav-
iour and that a continuum of genetic risk is likely to
extend from normal to abnormal behaviour (including psy-
chiatric illnesses such as schizophrenia). Attempts to
determine the mode of transmission of schizophrenia
using mathematical models of transmission patterns and
segregation studies of families have been inconclusive [4].
The weight of evidence is against a model in which a
single gene (a single major locus) is the only source of
family resemblance for the schizophrenic phenotype —
the risks of schizophrenia in different classes of relative to
an affected individual do not conform with those pre-
dicted by a simple Mendelian pattern of transmission.
This has led to the ‘oligogenic’ model [7], in which a small
number of genes with multiplicative effects are the deter-
mining factors. A single major locus is not, however,
rejected as part of a mixed, multifactorial model in which a
gene of major effect acts in combination with oligogenes,
polygenes and the environment. 
Molecular genetic approaches
The exact aetiological role of genetic factors and their
pattern of transmission can only be presumed until muta-
tions in specific genetic loci are found in affected persons,
obligate carriers and at-risk individuals. A number of mol-
ecular genetic methods have been used to try to detect
and locate susceptibility loci [8]. Even though a
Mendelian, single-gene inheritance pattern is not the
norm, some families of this type may exist and affected
members may be informative in the search for predispos-
ing loci using positional cloning techniques (reverse
genetics). The use of highly familial subforms has proved
to be a successful approach in other complex disorders
such as Alzheimer’s disease, non-insulin-dependent dia-
betes and breast cancer. The first step is to find a ‘linkage’
between a polymorphic genetic marker, which defines a
region of the genome, and the putative disease locus.
Linkage studies for disease genes examine the segregation
of alleles at a marker locus in families containing multiple
members affected with the disease. A marker close to, or
within, the gene of interest will be passed from parent to
child with the gene, and one can therefore use the marker
to see whether a particular allele of the gene co-segregates
with the disease in affected families. The aim is to detect
departure from independent assortment (and hence infer
linkage), and to estimate the genetic distance between the
two loci. Significant evidence of linkage between a marker
and a disease demonstrates the existence of a major locus
for the disease, and localizes it to a region for further
investigation. The classic way to measure this evidence is
by the ‘lod’ score — the logarithm of the odds ratio (the
relative likelihoods of linkage versus no linkage).
The application of the lod-score method to schizophrenia
has been fraught with problems, as it requires the use of
parameters (gene frequency, penetrance and phenocopy
rates) to describe the transmission of the trait. As the
mode of transmission of schizophrenia is unknown, a
number of different genetic models may be tested in the
statistical analysis, increasing the probability of a false-
positive finding. Other problems arise because of uncer-
tainty in diagnostic criteria for affected individuals,
genetic heterogeneity, phenocopies and incomplete pene-
trance. Furthermore, the lod-score method may not be the
most appropriate for the analysis of complex genetic
disorders if there are no genes of major effect. 
One way to overcome the problem of deducing the
parameters of transmission is to use allele-sharing
methods. Affected relative pairs are used to determine
whether the alleles of a marker are shared more often
than would be expected by chance; affected relatives
should show excess allele sharing even in the presence of
incomplete penetrance, genetic heterogeneity and high-
frequency disease alleles. Several robust, non-parametric
linkage methods have been proposed which are often
used with the lod-score method to safeguard against false-
negative findings due to incorrect specification of the
inheritance model.
By focusing on highly familial subforms of schizophrenia,
these linkage methods have been used in attempts to
deduce the genetic component of the illness. Initially,
studies focused on candidate genes and regions of the
genome (reviewed in [3]). For example, the segregation of
chromosome abnormalities with schizophrenia in certain
families provided the impetus for researchers to attempt
linkage studies of chromosome 5. This led to the emer-
gence, in 1988, of the first claim for the existence of a
schizophrenia locus on the long arm (q) of chromosome 5
[9]. Unfortunately, this finding was never confirmed.
Given the complexity and unknown pathogenesis of
schizophrenia, it may be more productive to conduct a sys-
tematic search of the entire genome as part of a positional
cloning strategy. Until recently, the successful dissection
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of complex traits by genome-wide linkage mapping was
restricted to experimental organisms such as mice. When
dense maps of highly polymorphic microsatellite markers
throughout the human genome became available, system-
atic genome scans were initiated. Initial results of system-
atic genomic searches using highly polymorphic, evenly
spaced genetic markers found small positive lod scores for
markers from the long arm of chromosome 22 [10]. This
region maintains interest as replication studies have been
supportive, and significant results have been obtained
using non-parametric methods in a large collaborative
data set [11].
Chromosome 6p
Recent advances in technology mean that the accuracy,
speed and efficiency of genotyping of microsatellite
markers can be facilitated by fluorescent labelling and
automation. In a pilot test of automated genotyping strate-
gies for a genomic scan, using 186 Irish pedigrees, an
Irish–American group of researchers provided the first
report of a possible susceptibility locus for schizophrenia
on distal chromosome 6p (D6S260) [12]. Although the lod
scores were significantly positive, they could still be
obtained by chance one in 40 times in a genome scan.
Consequently, independent studies were required to
provide more convincing evidence.
Moises and colleagues [13] used a genome scan in three
phases, in principle providing built-in validation. In the
first stage, they used five families with a total of 37
affected individuals from Iceland (a geographic isolate,
intended to reduce the possibility of heterogeneity within
the sample studied). Screening with 413 markers, and using
a non-parametric analysis, produced 26 ‘interesting’ areas
for further investigation. Ten of these were selected for the
second stage and tested in a total of 65 families from
numerous populations. This material revealed some evi-
dence for linkage to four loci. When results from the first
and second stages were combined and analyzed, the statisti-
cal evidence for linkage increased slightly for loci on chro-
mosomes 6p, 8p and 20. The most stringent significance
level could be reached only for 6p, and then only after a
third population sample was added — 113 schizophrenic
patients and their unaffected parents from China.
Markers in this region have also been tested for linkage in
an extension of the Irish data set used in the original work
implicating 6p [14]. By looking at 265 pedigrees, there is
significant evidence, from a lod-score analysis assuming
locus heterogeneity, for linkage on 6p. Families from
Germany [15] and the United States [16], tested in two
independent studies, also provide suggestive evidence for
linkage of a schizophrenia susceptibility locus to this
region. Together, these four reports [13–16], which take in
a total of 430 families from different populations plus 113
schizophrenics with unaffected parents from China,
suggest that chromosome 6p does indeed carry a locus that
predisposes to schizophrenia. Weight should be given to
replication of the finding by several different groups,
despite differences in diagnostic schemes and methods of
analysis. These studies also show that locus heterogeneity
is likely — the presumed gene on 6p is thought to account
for the genetic vulnerability to schizophrenia in up to
30 % of the families studied.
The evidence implicating a locus on 6p is the strongest to
date in schizophrenia genetics, and efforts are already
underway to refine the location and search for coding
sequences. The region implicated is, however, quite large
(Fig. 1). The most suggestive lod scores were obtained on
two regions some 20 cM apart, probably reflecting differ-
ent informativeness of the markers in individual data sets
and imprecise definition of inheritance pattern, rather
than true loci. The combined data suggest a wide region,
close to 30 cM long and containing maybe hundreds of
genes, at 6p21–24. It is interesting to speculate on what
type of gene(s) may have a role in schizophrenia. Will it be
one gene, such as a gene encoding a transcription factor
that controls the expression of a number of genes? Or will
it be a gene with a role in one of the biological theories for
schizophrenia — predominantly alterations of neurodevel-
opment, neurochemistry and immune/autoimmune reac-
tions? It is particularly poignant that the HLA (Human
Leukocyte antigen) region, highly involved in immune
and autoimmune reactions and shown previously to have
allelic associations with schizophrenia, is on the edge of
the implicated region.
Figure 1
Human chromosome 6, showing genetic markers used in recent
studies which indicate that the 6p21–24 region may contain a
susceptibility locus for schizophrenia. HLA, human leukocyte antigen.
Other possible loci
One of the assumptions of linkage analysis is that there is
a gene of major effect, and that familial schizophrenia
may be a subtype. To detect genes of smaller effect,
association analysis can be used to compare the fre-
quency of marker alleles in a sample of patients with eth-
nically matched controls. A significantly higher
frequency of the marker allele in the patient group sug-
gests either that the marker itself has some direct influ-
ence on susceptibility to the disease or that it is in
linkage disequilibrium with a susceptibility locus.
Current interest in association studies of schizophrenia
focuses on functionally significant variations in candidate
genes. For example, following the use of drug treatment
for schizophrenia and emergence of the ‘dopamine
hypothesis’, many linkage studies have tried, with no
success, to show a major role for the genes encoding the
dopamine receptors and dopamine metabolizing
enzymes. However, association studies, in particular of
the dopamine D3 receptor gene, have been more encour-
aging. A common variation in the first exon of this gene
results in a restriction-fragment length polymorphism; an
increased incidence of homozygosity for this polymor-
phism in schizophrenics compared with controls has
been reported by several research groups.
Other recent research suggests that the genetic aetiology
of schizophrenia may involve expanded triplet repeats of
DNA. Such motifs have been shown for a number of neu-
rological disorders (reviewed in [17]), and in many cases
they are the cause of anticipation (an inheritance pattern
within a pedigree wherein disease severity increases or
age of onset decreases in successive generations). Recent
studies suggesting that anticipation occurs in schizophre-
nia pedigrees (reviewed in [18]) replicate a phenomena
that was noted as early as 1910 by Mott. However, family
studies seeking anticipation are prone to a number of
ascertainment biases, and direct evidence for anticipation
using molecular genetic methods such as RED (repeat
expansion detection) to detect expanded triplet repeats
has been sought. Expanded CAG repeats have recently
been reported in the DNA of schizophrenic individuals
[19], especially those with an early age of onset of the
illness and female patients [20].
The search for genes predisposing to schizophrenia has
been frustrating, and characterized by failure to replicate
initial positive linkages. However, contemporary studies
have now reached a size and sophistication that command
more respect than their precursors. No definite results
have yet emerged. However, several ‘hot spots’ are
currently the subject of intensive investigation, the most
promising of which is at 6p21–24. Whether the belief that
this region contains a major predisposing gene for
schizophrenia is a collective delusion or not, should shortly
be resolved.
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